Table 1.
Clinicopathologic characteristics of patients with resectable CRLM.
Table 2.
Mortality and morbidity of resectable patients.
Figure 1.
Survival of patients with resectable CRLM after liver resection.
Fig. 1A Kaplan–Meier curves illustrating survival of all patients with resectable CRLM after liver resection. A total of 466 resectable patients had a median survival of 56.1 months and a 5-year survival rate of 49%. Fig. 1B Kaplan–Meier curves illustrating survival of resectable patients with or without neoadjuvant chemotherapy. 121 patients with neoadjuvant chemotherapy had a median survival of 60.0 months and a 5-year survival rate of 52%, whereas those without neoadjuvant chemotherapy had a similar median survival of 53.4 months and a 5-year survival rate of 48%. Fig. 1C Kaplan–Meier curves illustrating survival of low-risk patients with or without neoadjuvant chemotherapy. In the low-risk group, the patients with and without neoadjuvant chemotherapy had similar survival (median survival, 60.0 m vs. 60.0 m; 5-year survival, 64% vs. 57%; P>0.05). Fig. 1D Kaplan–Meier curves illustrating survival of high-risk patients with or without neoadjuvant chemotherapy. In the high-risk group, patients who had received neoadjuvant chemotherapy had a better overall median survival (38.9 m vs. 28.4 m) and a more favorable 5-year overall survival (39% vs. 33%; P = 0.028) than those had not received neoadjuvant chemotherapy.
Table 3.
Clinicopathological characteristic associated with overall survival.